Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1044 of 1,261

  1. US 7470790

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  2. US 7470506

    Fitness assay and associated methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  3. US 7470420

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  4. US 7470430

    Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  5. US 7470431

    Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

    The Regents of the University of Colorado · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  6. US 7470659

    Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)

    The Regents of the University of California · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  7. US 7470700

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  8. US 7468352

    Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  9. US 7468432

    Cobalamin conjugates useful as antitumor agents

    Regents of the University of Minnesota · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  10. US 7468444

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  11. US 7468435

    Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  12. US 7468419

    Cyclosporin derivatives for the treatment of immune disorders

    Enanta Pharmaceuticals, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  13. US 7468394

    Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation

    Amphastar Pharmaceuticals, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  14. US 7468426

    Oncoprotein protein kinase antibody kit

    The Regents of the University of California · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  15. US 7468379

    Inhibition of osteolytic lesions by SRC kinase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  16. US 7468420

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  17. US 7465449

    Anti-αvβ6 antibodies

    The Regents of the University of California · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  18. US 7465815

    Cannabinoid receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  19. US 7465738

    Compounds useful as promoters of SMN2

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  20. US 7465466

    Compositions and methods for prostate and kidney health and disorders, an herbal preparation

    Integrated Chinese Medicine Holdings Ltd. · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  21. US 7465825

    Phenyl substituted carboxylic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  22. US 7465831

    Levalbuterol hydrochloride Polymorph A

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  23. US 7465784

    Antimicrobial peptides and methods of identifying the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  24. US 7465748

    Amide derivative

    Rational Drug Design Laboratories · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.